![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, February 01, 2009 2:09:03 PM
This statement you made is incorrect, and appears to be based on an outdated outstanding share count: "With today's share price, total market cap is still about one thirteenth of what we know this company owes to creditors."
I have yet to see an online service, that updates outstanding share count correctly. The generally accepted procedure is to call the registrar, for current share count, and not trust what the online services display, for that figure.
When I last called the registrar, on 1/28/2008, DNAG's outstanding share count was:
1,294,790,465 (unchanged since at least 11/17/2008)
Authorized share count remained unchanged, also:
1,500,000,000
Using current share count, at Friday's closing price of .0013, market cap is a little over $1.68M. Multiply that by 13 (to check your scenario) and the result is around $22M. I have seen no estimate that claims their debt is so high; the estimates I've seen have all been much closer to $10M, so instead of 1/13th, the actual number is probably much closer to 1/6th. As we know, DNAG market cap has increased considerably, in recent months. I would not be surprised to see DNAG's market cap surge past $10M, or even $100M, relatively quickly.
Registrar contact information:
Standard Registrar & Transfer
12528 S 1840 E, Draper, UT 84020-9100, United States
Phone: (801) 571-8844
As it becomes obvious to more investors, that DNAPrint Genomics and all of its assets (including intellectual property) is actually worth, with funding, far more than than what it owes to creditors, it makes sense that investors would be attracted, and securing new funding for DNAG becomes something that is much more likely. As I consider DNAG to be worth far more than $10M, I think that, for DNAG to not obtain funding, would represent a major missed investment opportunity. I also think that, if/when DNAG secures new funding (or income becomes sufficient to negate the need for additional funding,) share price would appreciate very dramatically.
Aside from the numbers I stated above, these statements are my opinions only, of course, but I think they are reasonable.
Daniel
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM